Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers

Trial Profile

Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2018

At a glance

  • Drugs ACT 1 (Primary)
  • Indications Leg ulcer
  • Focus Pharmacokinetics
  • Sponsors FirstString Research
  • Most Recent Events

    • 06 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Apr 2019.
    • 06 Feb 2018 Status changed from recruiting to active, no longer recruiting.
    • 28 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top